Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Kliem

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Clinical Nephrology|April 18, 2001
Detection of significant renal artery stenosis with color Doppler sonography: combining extrarenal and intrarenal approaches to minimize technical failureJ Radermacher, A Chavan, J Schäffer, et al.
Transplantation|November 27, 1996
The long-term course of hepatitis C after kidney transplantationV Kliem, U van den Hoff, R Brunkhorst, et al.
British Journal of Clinical Pharmacology|June 1, 1996
Diltiazem increases blood concentrations of cyclized cyclosporine metabolites resulting in different cyclosporine metabolite patterns in stable male and female renal allograft recipientsJ S Bleck, C Thiesemann, V Kliem, et al.
Clinical Nephrology|April 10, 2009
Geographical prevalence, risk factors and impact of hepatitis B and C after renal transplantationV Kliem, U Michel, M Burg, et al.
Transplantation Proceedings|December 31, 2003
One-year posttransplant renal function is a strong predictor of long-term kidney function: results from the Neoral-MOST Observational StudyM Salvadori, A Rosati, A Bock, et al.
Transplantation Proceedings|April 6, 2005
Delayed graft function: risk factors, consequences and parameters affecting outcome-results from MOST, A Multinational Observational StudyY Lebranchu, J M Halimi, A Bock, et al.
Transplantation Proceedings|May 4, 2005
Cyclosporine-based immunosuppressive strategies for kidney recipients: interim analysis of German data from the Multinational Observational Study (MOST)V Kliem, L Fritsche, H Haller, et al.
Transplantation Proceedings|June 17, 2008
Relationship of hepatitis B or C virus prevalences, risk factors, and outcomes in renal transplant recipients: analysis of German dataV Kliem, M Burg, H Haller, et al.
Transplantation Proceedings|September 27, 2005
Impact of mycophenolate mofetil dose posttransplantation on 12-month renal function: analysis of the MOST databaseM Salvadori, A Bock, J Chapman, et al.
Gut|April 17, 2001
Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver diseaseH L Tillmann, D F Chen, C Trautwein, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Clinical Nephrology|April 18, 2001
Detection of significant renal artery stenosis with color Doppler sonography: combining extrarenal and intrarenal approaches to minimize technical failureJ Radermacher, A Chavan, J Schäffer, et al.
Transplantation|November 27, 1996
The long-term course of hepatitis C after kidney transplantationV Kliem, U van den Hoff, R Brunkhorst, et al.
British Journal of Clinical Pharmacology|June 1, 1996
Diltiazem increases blood concentrations of cyclized cyclosporine metabolites resulting in different cyclosporine metabolite patterns in stable male and female renal allograft recipientsJ S Bleck, C Thiesemann, V Kliem, et al.
Clinical Nephrology|April 10, 2009
Geographical prevalence, risk factors and impact of hepatitis B and C after renal transplantationV Kliem, U Michel, M Burg, et al.
Transplantation Proceedings|December 31, 2003
One-year posttransplant renal function is a strong predictor of long-term kidney function: results from the Neoral-MOST Observational StudyM Salvadori, A Rosati, A Bock, et al.
Transplantation Proceedings|April 6, 2005
Delayed graft function: risk factors, consequences and parameters affecting outcome-results from MOST, A Multinational Observational StudyY Lebranchu, J M Halimi, A Bock, et al.
Transplantation Proceedings|May 4, 2005
Cyclosporine-based immunosuppressive strategies for kidney recipients: interim analysis of German data from the Multinational Observational Study (MOST)V Kliem, L Fritsche, H Haller, et al.
Transplantation Proceedings|June 17, 2008
Relationship of hepatitis B or C virus prevalences, risk factors, and outcomes in renal transplant recipients: analysis of German dataV Kliem, M Burg, H Haller, et al.
Transplantation Proceedings|September 27, 2005
Impact of mycophenolate mofetil dose posttransplantation on 12-month renal function: analysis of the MOST databaseM Salvadori, A Bock, J Chapman, et al.
Gut|April 17, 2001
Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver diseaseH L Tillmann, D F Chen, C Trautwein, et al.
Pageof 6